emory医疗保健将利用nference最先进的功能，安全地消除健康信息的识别，并为卫生系统提供有关患者疾病、治疗和结果的宝贵见解。 --getty imagescambridge，mass。 –nference是一家以科学为先的软件公司，将医疗保健数据转化为研究和发现，emory healthcare是佐治亚州最全面的学术健康系统，今天宣布了一项协议，以扩大对多样化、聚合、去识别数据的访问，目标是加快突破性的研究、疾病诊断和新的治疗方法。 这种合作符合一个共同的使命，即促进知识，促进创新，改善世界各地个人和社区的健康和福祉。 nference联合创始人兼首席执行官穆拉利·阿拉瓦穆丹表示：“随着我们继续推进与世界上最好的学术医疗中心的深度合作，我们的多模式人工智能平台将能够发现拯救生命的药物，推进下一代干预措施的开发，并通过数字化以前所未有的规模改变临床实践。”。 emory医疗保健由11家医院、emory诊所和250多个医疗机构组成。 作为肿瘤学、老年医学、神经病学/神经外科、产科/妇科和泌尿外科的国家领导者，emory与nference的合作将支持这些治疗领域的研究，并扩展nference联邦数据网络，提供多样化的多模式（临床和成像）数据，用于真实世界的证据研究和人工智能模型开发。 emory医疗保健将利用nference最先进的功能，安全地消除健康信息的识别，并为卫生系统提供有关患者疾病、治疗和结果的宝贵见解。 埃默里医疗保健和埃默里大学首席数据和分析官joedepa表示：“在埃默里医疗，我们致力于卓越的研究，并认识到现实世界证据对解决患者群体未满足需求的重要性。”。 “与nference的合作使我们能够加入由领先机构组成的联邦数据网络，从而实现突破性的研究。 我们可以共同努力，改善生活，提供希望，应对我们这个时代最关键的医疗保健挑战，同时提供全面的、数据驱动的见解。 “nference的nsiights平台于2022年9月推出，使研究能够通过联邦数据网络为客户提供从所有治疗领域（包括心脏病学、肿瘤学、代谢疾病、免疫学和传染病）的精心策划的、未经识别的数据集中获得的见解。 该平台允许科学家和临床医生在保护患者隐私的同时，通过为大规模研究建立高度特定的团队来转变发现并加速开发。 未识别的数据在源位置保留在防火墙后面，只能在nsiights上访问，从而维护数据的安全性和机密性。 关于nference通过其强大的技术平台和软件，nference正在通过使生物医学知识可计算来改变医疗保健。 它与主要学术医疗中心的合作使nference能够综合数十年的机构知识，通过将大量未识别的数据转换为深入的见解来实时生成真实世界的证据，从而推动诊断和治疗的发现和开发。 其专有的人工智能软件平台nsiights利用联合学习的力量，以重要的方式加速生命科学的研究、开发和临床护理，包括生物标志物的发现和验证、利用真实世界数据的rwe生成、早期疾病检测、公共卫生政策的生成和验证等。 nference的总部设在马萨诸塞州的剑桥。 在linkedin和twitter上关注会议。 访问我们的www。 会议。 通用域名格式。 关于emory healthcaremory heahealthcare拥有近24000名员工和11家医院，是佐治亚州最全面的学术卫生系统。 在全系统范围内，它拥有2796张有执照的病床，3450多名医生在70多个专业执业，服务于亚特兰大和乔治亚州。 它还通过st的合资企业为大乔治亚州提供服务。 位于哥伦布的弗朗西斯-埃默里医疗保健医院、10家地区附属医院及其临床综合医生网络。 欲了解更多信息，请访问emory healthcare。 欲了解更多信息，请访问emory healthcare。emory healthcare will leverage nference’s state-of-the-art capabilities to securely de-identify health information and provide the health system with valuable insights about diseases, treatments and outcomes for patients. — getty imagescambridge, mass. – nference, a science-first software company transforming health care data for research and discovery, and emory healthcare, the most comprehensive academic health system in georgia, today announced an agreement to expand access to diverse, aggregated, de-identified data with the goal of accelerating groundbreaking research, disease diagnoses and new treatments. this collaboration aligns with a shared mission to advance knowledge, promote innovation and improve the health and well-being of individuals and communities worldwide.“as we continue to advance deep collaborations with the worlds best academic medical centers, our multimodal ai platform will enable the discovery of life-saving medicine, advance the development of next-generation interventions, and transform clinical practice through digitization at an unprecedented scale,” says murali aravamudan, co-founder and ceo of nference.emory healthcare is comprised of 11 hospitals, the emory clinic and more than 250 provider locations. as a national leader in oncology, geriatrics, neurology/neurosurgery, obstetrics/gynecology and urology, emory’s collaboration with nference will support research in these therapeutic areas and expand the nference federated data network with diverse, multimodal (clinical & imaging) data for real-world evidence research and ai model development. emory healthcare will leverage nference’s state-of-the-art capabilities to securely de-identify health information and provide the health system with valuable insights about diseases, treatments and outcomes for patients.“at emory healthcare, we are committed to research excellence and recognize the significance of real-world evidence for addressing unmet needs in patient populations,” says joe depa, chief data and analytics officer at emory healthcare and emory university. “this collaboration with nference allows us to join a federated data network of leading institutions that will enable ground-breaking research. together, we can work to improve lives and provide hope, tackling some of the most critical health care challenges of our time while delivering comprehensive, data-driven insights.”nference’s nsights platform, which launched september 2022, enables research via the federated data network to provide customers with access to insights from a curated, de-identified dataset available across all therapeutic areas, including cardiology, oncology, metabolic diseases, immunology and infectious diseases. the platform allows scientists and clinicians to transform discovery and accelerate development by building highly specific cohorts for large-scale research while preserving patient privacy. de-identified data remains behind firewalls at the source and is only accessible on nsights, maintaining data security and confidentiality. about nferencethrough its powerful technology platform and software, nference is transforming health care by making biomedical knowledge computable. its partnership with major academic medical centers empowers nference to synthesize decades of institutional knowledge, producing real-world evidence (rwe) in real time by converting large amounts of de-identified data into deep insights to advance discovery and development of diagnostics and therapeutics. its proprietary ai-enabled software platform, nsights, harnesses the power of federated learning to accelerate life sciences research, development and clinical care in significant ways, including biomarker discovery and validation, rwe generation leveraging real-world data, early disease detection, public health policy generation and validation and more. nference is headquartered in cambridge, massachusetts. follow nference on linkedin and twitter. visit us at www.nference.com. about emory healthcareemory healthcare, with nearly 24,000 employees and 11 hospitals, is the most comprehensive academic health system in georgia. system-wide, it has 2,796 licensed patient beds and more than 3,450 physicians practicing in more than 70 specialties, serving metro atlanta and georgia. it also provides services to greater georgia through a joint venture at st. francis–emory healthcare hospital in columbus, 10 regional affiliate hospitals, and its clinically integrated physician network. for more, visit emory healthcare. .亲，点击此处在线申请留学咨询服务和报名评估！我们将竭诚提供最佳评估服务！
